Evidence map›Paper›PMID 17289562›Full record

ArticleCell2007

Visualizing the histone code on LSD1.

Matthew J Gamble, W Lee Kraus

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.International journal of biological sciences · 2018
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Matthew J GambleDepartment of Molecular Biology and Genetics, 465 Biotechnology Building, Cornell University, Ithaca, NY 14853, USA.
W Lee Kraus

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this issue, Garcia-Bassets et al. (2007) show that spurious transcriptional activation by unliganded nuclear receptors is inhibited by histone lysine methylation. This inhibitory histone modification code is efficiently countered by the ligand-dependent recruitment of histone lysine demethylases, including lysine-specific demethylase 1 (LSD1), which appear to be used for this purpose by a number of signal-regulated transcriptional activators.

Indexed as

Gene Expression RegulationHistone CodeCell Line, TumorEstrogen Receptor alphaHistone DemethylasesHistone-Lysine N-MethyltransferaseHistonesHumansLigandsMethylationOxidoreductases, N-DemethylatingTranscriptional ActivationEstrogen Receptor alphaHistone DemethylasesHistone-Lysine N-MethyltransferaseHistonesKDM1A protein, humanLigandsOxidoreductases, N-Demethylating

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.